10月21日港股创新药ETF（513120）份额减少2700.00万份，最新份额165.22亿份，最新规模229.51亿元

Core Insights - The Hong Kong Innovative Drug ETF (513120) increased by 1.30% on October 21, with a trading volume of 6.146 billion yuan [1] - The fund's shares decreased by 27 million, bringing the total shares to 16.522 billion, with an increase of 327 million shares over the past 20 trading days [1] - The latest net asset value of the fund is 22.951 billion yuan [1] - The fund's performance benchmark is the return rate of the CSI Hong Kong Innovative Drug Index (in RMB) [1] - Managed by Guangfa Fund Management Co., Ltd., the fund has a return of 38.90% since its inception on July 1, 2022, but has seen a decline of 7.09% over the past month [1]